![The head of the FDA is calling for an investigation into her agency's controversial decision to approve a new Alzheimer's drug](https://cdn.newsserve.net/ONPglobe256.png)
The head of the FDA is calling for an investigation into her agency's controversial decision to approve a new Alzheimer's drug
The decision to approve Aduhelm has raised concerns and led three advisors to resign. The agency's head is now asking for an outside investigation.
Full Article